Regulating pharmacist services: Achieving a full scope of practice

Tsuyuki RT Houle SKD Okada H . Time to give up on expanded scope of practice. Can Pharm J (Ott) 2018;151(5):286.

Canadian Pharmacists Association. Pharmacists’ expanded scope of practice in Canada. June 2015. Available: https://www.pharmacists.ca/cpha-ca/assets/File/news-events/ExpandedScopeChart_June2015_EN.pdf (accessed Mar. 19, 2023).

Tsuyuki RT Davies NM . Self-denigration in pharmacy: words to banish from the pharmacy lexicon. Can Pharm J (Ott) 2014;147(4):197-9.

Hogue MD Grabenstein JD Foster SL Rothholz MC . Pharmacist involvement with immunizations: a decade of professional advancement. J Am Pharm Assoc 2006;46(2):168-79.

Roberts GE Rubin SE Smith JK Adams AJ Klepser DG . Public health perceptions of community pharmacy partnership opportunities. J Public Health Manag Pract 2015;21(4):413-5.

Rosenthal M Austin Z Tsuyuki RT . Are pharmacists the ultimate barrier to pharmacy practice change? Can Pharm J (Ott) 2010;143(1):37-42.

Adams AJ . Pharmacist prescriptive authority: lessons from Idaho. Pharmacy (Basel) 2020;8:112.

Adams AJ . Prescription adaptation services: a regulatory and practice perspective. Ann Pharmacother 2018;52(7):700-3.

Tsuyuki RT . FAQs (frequent asinine questions) on pharmacists’ scope of practice. Can Pharm J (Ott) 2018;151(4):212-3.

Beahm NP Smyth DJ Tsuyuki RT . Outcomes of Urinary Tract Infection Management by Pharmacists (RxOUTMAP): a study of pharmacist prescribing and care in patients with uncomplicated urinary tract infections in the community. Can Pharm J (Ott) 2018;151(5):305-14.

Hind C . NHS Grampian project: treating uncomplicated lower urinary tract infection in community pharmacy. Pharm J 2018;10:1.

Gauld NJ Zeng IS Ikram RB Thomas MG Buetow SA . Antibiotic treatment of women with uncomplicated cystitis before and after allowing pharmacist-supply of trimethoprim. Int J Clin Pharm 2017;39(1):165-72.

Akers JM Adams AJ Klepser ME . Review of pharmacy-based management of uncomplicated urinary tract infections (UTIs) in community pharmacy settings. Int J Pharm 2018;8(2):63-9. Available: http://pharmascholars.com/abstractview/review-of-pharmacy-based-management-of-uncomplicated-urinary-tract-infections-utis-in-community-pharmacy-settings (accessed Feb. 4, 2023).

Wong ES McKevitt M Running K Counts GW Turck M Stamm WE . Management of recurrent urinary tract infections with patient-administered single-dose therapy. Ann Intern Med 1985;102:302-7.

Schauberger CW Merkitch KW Prell AM . Acute cystitis in women: experience with a telephone-based algorithm. WMJ 2007;106(6):326-9.

Adams AJ Adams JL . Does increased state pharmacy regulatory burden lead to better public safety outcomes? Innov Pharm 2021;12(1):19.

Idaho Board of Pharmacy. 27.01.04—Rules governing pharmacist prescriptive authority. 2018 Archive. Available: https://adminrules.idaho.gov/rules/2018%20Archive/27/270104.pdf (accessed Mar. 19, 2023).

Idaho Board of Pharmacy. 27.01.04—Rules governing pharmacist prescriptive authority. 2019 Archive. Available: https://adminrules.idaho.gov/rules/2019%20Archive%20C1/27/270104.pdf (accessed Mar. 19, 2023).

Adams JA Adams AJ Klepser ME . Pharmacist prescriptive authority for acne: an evidence-based approach to policy. Innov Pharm 2021;(12)2:10.24926/iip.v12i2.3897.

Menon C Gipson K Bowe WP Hoffstad OJ Margolis DJ . Validity of subject self-report for acne. Dermatology 2008;317(2):164-8.

Taylor J . Minor ailment prescribing: part II—physician feedback. Self Care 2016;7:22-40.

Taylor JG Joubert R . Pharmacist-led minor ailment programs: a Canadian perspective. Int J Gen Med 2016;9:291-302.

Noseworthy J LeBlanc C . Minor ailments across Canadian jurisdictions. Can Pharm J (Ott) 2013;145(5):296-301.

Nakhla N Shiamptanis A . Pharmacist prescribing for minor ailments service development: the experience in Ontario. Pharmacy 2021;9(2):96.

Adams AJ . Transitioning pharmacy to “standard of care” regulation: analyzing how pharmacy regulates relative to medicine and nursing. Res Social Adm Pharm 2019;15(10):1230-35.

Moffett P Moore G . The standard of care: legal history and definitions: the bad and good news. West J Emerg Med 2011;12(1):109-12.

Adams AJ Chopski NL . Rethinking pharmacy regulation: core elements of Idaho’s transition to a “standard of care” approach. J Am Pharm Assoc 2020;60(6):E109-12.

Adams AJ Klepser DG Klepser ME Adams JL . Pharmacy-based point-of-care testing: how a “standard of care” approach can facilitate sustainability. Innov Pharm 2021;12(4):Article 16.

Idaho Code. 54-1705. Definitions . 2023. Available: https://legislature.idaho.gov/statutesrules/idstat/Title54/T54CH17/SECT54-1705/ (accessed Mar. 19, 2023).

Vanderholm T Renner HM Stolpe SF Adams AJ . An innovative approach to improving the proposed CMS star rating “Statin use in persons with diabetes.” J Manag Care Spec Pharm 2018;24(11):1126-9.

Yuksel N Eberhart G Bungard TJ . Prescribing by pharmacists in Alberta. Am J Health System Pharm 2008;65(22):2126-32.

Charrois T Rosenthal M Tsuyuki RT . Stories from the trenches: experiences of Alberta pharmacists in obtaining additional prescribing authority. Can Pharm J (Ott) 2012;145(1):30-4.

Arkansas State Board of Pharmacy. Pharmacist prescribing of self-administered oral contraceptive therapy. Statewide protocol. 2020. Available: https://apa.memberclicks.net/assets/Protocols/OC%20Protocol%20-%20Final.pdf (accessed Feb. 4, 2023).

Ohio Board of Pharmacy. Protocol for dispensing naloxone to individuals at risk of experiencing or witnessing an opioid-related overdose. March 2022. Available https://pharmacy.ohio.gov/Documents/Pubs/Naloxone/Pharmacist/Guidance%20Document%20-%20Dispensing%20of%20Naloxone%20without%20a%20Prescription.pdf (accessed Feb. 26, 2023).

Adams AJ Frost TP . The over-regulation of pharmacist-services: why over-the-counter naloxone should spark conversation about a “standard of care” regulatory approach. J Am Coll Clin Pharm 2023;6(6):615-20.